MetLife (MET) Q2 2026 earnings review
Strong Underwriting and Broad Growth Propel Adjusted Earnings
MetLife delivered a robust Q2 2026, driven by the successful execution of its 'New Frontier' strategy. Adjusted EPS surged 20% YoY to $2.43, and adjusted earnings rose 15% to $1.6 billion. The story of the quarter was a sharp recovery in Group Benefits underwriting and broad volume growth across international segments. Adjusted return on equity (ROE) hit 17.0%, sitting at the top of management's target range. However, top-line GAAP Net Income was essentially flat (+1% YoY) at $705 million, as severe net derivative losses stemming from market volatility continued to obscure the underlying fundamental strength of the business.
🐂 Bull Case
After struggling with non-medical health underwriting a year ago, Group Benefits reversed course, growing adjusted earnings 25% YoY to $503 million.
MetLife continues aggressive capital deployment, returning over $1.1 billion to shareholders in Q2 via share repurchases ($700 million) and dividends ($400 million), supporting massive EPS accretion.
🐻 Bear Case
GAAP Net Income continues to be dragged down by massive non-economic accounting volatility. Net derivative losses were $772 million for the quarter, driven by higher interest rates and a stronger U.S. dollar.
The Retirement and Income Solutions (RIS) segment eked out just 2% adjusted earnings growth YoY, hampered by lower variable investment income.
⚖️ Verdict: 🟢
Bullish. The core insurance and asset management operations are firing on all cylinders. The 20% adjusted EPS growth and 17% adjusted ROE prove that the 'New Frontier' strategy is actively expanding margins despite noisy GAAP headline numbers.
Key Themes
Group Benefits Underwriting Rebound
Reversing. A year ago, Group Benefits faced elevated non-medical health claims. In 26Q2, the segment posted a 25% surge in adjusted earnings to $503 million. This reflects favorable underwriting normalization and solid 4% growth in adjusted premiums and fees (excluding participating contracts).
International Volume Growth
Accelerating. Asia adjusted earnings jumped 25% on a constant currency basis to $420 million, and EMEA grew 11% to $108 million. Broad-based volume growth and favorable market factors are successfully insulating MetLife from North American market cyclicality.
MIM Segment Scale via PineBridge
Accelerating. MetLife Investment Management (MIM) saw assets under management (AUM) swell 20% YoY to $748.1 billion, largely reflecting the successful acquisition of PineBridge Investments. Other revenues for the segment jumped 34% to $317 million.
Retirement & Income Solutions (RIS) Lagging
Decelerating. While overall company adjusted earnings grew 15%, the RIS segment managed only 2% YoY growth to $377 million. Despite 19% growth in adjusted premiums (excluding PRT) driven by U.K. longevity reinsurance, lower variable investment income severely capped bottom-line growth, directly contradicting the broader 'broad-based growth' narrative.
Macro Volatility Pressuring GAAP Results
Stable. Management's narrative focuses entirely on adjusted earnings, but GAAP Net Income barely grew (+1%) due to $772 million in net derivative losses and $428 million in net investment losses. Stronger equity markets, a strong U.S. dollar, and higher long-term interest rates continue to create massive non-economic accounting noise.
Technology and AI Efficiency
Stable. The company reported a direct expense ratio (excluding notable items and PRT) of 12.1%, slightly up from 11.7% last year but exactly on track for their yearly target. Management's previous investments in the proprietary AI platform, 'MetIQ', appear to be keeping headcount and operational expenses well within targeted guardrails.
Corporate & Other Segment Drag
Stable. The Corporate & Other segment reported an adjusted loss of $160 million, widening from a loss of $142 million in the prior-year quarter. This structural drag on overall earnings persists as a headwind to enterprise profitability.
Other KPIs
Up 7% YoY from $5.20 billion in 25Q2. The growth reflects both asset accumulation and the benefits of reinvesting maturing assets in a higher-rate environment. Variable investment income (VII) also grew 18% YoY to $231 million.
Decreased slightly from the $3.9 billion reported in 26Q1 but remains comfortably within management's target buffer of $3.0 billion to $4.0 billion, providing ample dry powder for continued share repurchases in the back half of the year.
Guidance
Stable. Management noted that the Q2 direct expense ratio (excluding total notable items related to direct expenses and PRT) came in at 12.1%, maintaining that they are 'on track for our yearly target.' This confirms that expense levels are fully aligned with the operational plan.
Key Questions
Commercial Real Estate Exposure
With the commercial mortgage portfolio previously showing stress and requiring CECL reserve increases, how did the office and retail segments perform in Q2, and what are the expected credit loss trajectories for the remainder of the year?
MIM Outflows and Synergies
Given the $2 billion in institutional outflows reported in Q1 post-PineBridge integration, did third-party flows stabilize in Q2, and are cross-selling opportunities materializing?
Sustainability of Group Benefits Margins
Group Benefits underwriting swung from a massive headwind in 25Q2 to a massive tailwind in 26Q2. Has the non-medical health ratio permanently stabilized, or should investors expect continued quarterly volatility?